DHS 75.24(11)(h)
(h) If the assessing clinical staff identifies symptoms of a physical health problem during the assessment process, the service shall refer the individual for a physical health assessment conducted by medical personnel.
DHS 75.24(11)(i)
(i) If the assessing clinical staff identifies that an individual is pregnant at the time of the assessment, the service shall make a referral for prenatal care or ensure that the patient is already receiving prenatal care, and document efforts to coordinate care with prenatal care providers.
DHS 75.24(11)(j)
(j) In the event that the assessed level of care is not available, a service shall:
DHS 75.24(11)(j)1.
1. Document accurately the level of care indicated by the clinical assessment.
DHS 75.24(11)(j)2.
2. Indicate on the treatment plan what alternative level of care is available or agreed upon.
DHS 75.24(11)(j)3.
3. Identify on the treatment plan what efforts will be made to access the appropriate level of care, additional services or supports that will be offered to bridge the gap in level of care, and ongoing assessment for clinical needs and level of care review.
DHS 75.24(11)(k)
(k) For assessments completed by a substance abuse counselor in-training or a graduate student QTT, the assessment and recommendations shall be reviewed and signed by the clinical supervisor within 7 days of the assessment date.
DHS 75.24(11)(L)
(L) For a patient receiving mental health services under s.
DHS 75.50 or
75.56 who does not have a co-occurring substance use disorder, the requirement for ASAM or other department-approved level of care placement criteria is not required.
DHS 75.24(12)(a)(a) A service shall have written policies and procedures for referring patients to other service providers and for coordinating care with other providers.
DHS 75.24(12)(b)
(b) Policies and procedures shall include a description of follow-up activities to be completed to support that recommended care is received.
DHS 75.24(13)(a)(a) Clinical staff of a service shall develop a treatment plan for each patient.
DHS 75.24(13)(b)
(b) A patient's treatment plan shall represent an agreement between the service and the patient regarding needs identified in the clinical assessment, the patient's identified treatment goals, and treatment interventions and resources to be applied.
DHS 75.24(13)(c)
(c) When feasible, the treatment plan shall be developed in collaboration and with input from the patient's family or significant other, or other supportive persons identified by the patient.
DHS 75.24(13)(d)
(d) The treatment plan shall be signed by the patient, the primary counselor, and other behavioral health clinical staff, identified in the treatment plan.
DHS 75.24(13)(e)
(e) A treatment plan completed by a substance abuse counselor in-training or a graduate student QTT shall be reviewed and signed by the clinical supervisor within 14 days of the development of the plan or the next treatment plan review, whichever is earlier.
DHS 75.24(13)(f)
(f) The content of the treatment plan shall describe the identified needs and specify individualized treatment goals that are expressed in behavioral and measurable terms.
DHS 75.24(13)(g)
(g) The treatment plan shall specify each intervention applied to reach the treatment goals.
DHS 75.24(13)(h)
(h) The treatment plan shall be reviewed at the interval required by the patient's level of care or based on the patient's needs and clinical indication. The review shall be documented with a summary of progress and the signature of the patient and primary counselor.
DHS 75.24(13)(i)
(i) The treatment plan review shall include an updated level of care assessment which follows ASAM or other department-approved placement criteria and recommends continued stay, transfer, or discharge.
DHS 75.24(13)(j)
(j) An updated treatment plan shall be established during the review if there is a change in the patient's needs, goals, or interventions and resources to be applied. The updated treatment plan shall be signed by the patient, the primary counselor, and any other behavioral health clinical staff identified in the treatment plan.
DHS 75.24(13)(k)
(k) Treatment plan reviews and updates completed by a substance abuse counselor in-training or graduate student QTT shall be reviewed and signed by the clinical supervisor within 14 days of the review and update.
DHS 75.24(13)(L)
(L) For patients with co-occurring disorders receiving services under ss.
DHS 75.50,
75.51,
75.52,
75.54,
75.55,
75.56, and
75.59 service shall assign dually-credentialed clinicians whenever possible. When this is not possible, the service shall ensure that mental health needs and substance use needs are included in the treatment plan, and met by appropriately credentialed personnel.
DHS 75.24(13)(m)
(m) For a patient receiving mental health services under s.
DHS 75.50 or
75.56 who does not have a co-occurring substance use disorder, the requirement for ASAM or other department-approved level of care placement criteria and review is not required.
DHS 75.24(14)(a)(a) A service shall have a written policy and procedure that outlines the structure for clinical consultation.
DHS 75.24(14)(b)
(b) Clinical consultation applies to all clinical staff of a service.
DHS 75.24(14)(c)
(c) Clinical consultation shall be documented in the patient's case record.
DHS 75.24(14)(d)
(d) Clinical consultation for unlicensed staff shall be completed with a clinical supervisor and shall be documented with the clinical supervisor's signature. Clinical consultation for licensed professionals may occur with a clinical supervisor or another licensed professional who is a staff of the service.
DHS 75.24(14)(e)
(e) Clinical consultation is required for any of the following:
DHS 75.24(14)(e)1.
1. When a patient's substance use or mental health poses a significant risk to the individual, their family, or the community.
DHS 75.24(14)(e)3.
3. When an individual's symptoms, pattern of substance use, risk level, or placement criteria indicate transfer to a higher level of care.
DHS 75.24(14)(f)
(f) When a safety plan requires ongoing monitoring, clinical consultation shall be completed at clinically-determined intervals until the risk level is reduced or appropriately managed with services or collateral supports.
DHS 75.24(14)(g)
(g) When the recommended level of care cannot be determined, or is not available, or the individual has declined the recommended level of care, clinical consultation shall be completed at clinically-determined intervals until the appropriate level of care is determined, or obtained, or the individual's risk level decreases.
DHS 75.24(15)(a)(a) A service shall have a written policy and procedure that outlines the structure for clinical staffing.
DHS 75.24(15)(b)
(b) Clinical staffing applies to all clinical staff of a service, and includes the clinical supervisor and medical personnel. Clinical staffing is facilitated at intervals appropriate to the individual's needs and as prescribed based on the level of care.
DHS 75.24(15)(c)1.
1. Clinical staffing shall include the clinical supervisor of the service.
DHS 75.24(15)(c)2.
2. Clinical staffing shall include a patient's prescriber or medical personnel, if applicable.
DHS 75.24(15)(c)3.
3. Clinical staffing may be combined with treatment plan review and level of care review.
DHS 75.24(15)(c)4.
4. Clinical staffing shall be documented in the patient's clinical record.
DHS 75.24(16)(a)(a) A service shall document in the patient's record each contact the service has with a patient or with a collateral source.
DHS 75.24(16)(b)
(b) Notes shall be entered by the staff member providing the service to document the content of the contact with the patient or a collateral source; or, if notes are entered by a designee, this must be specified.
DHS 75.24(16)(c)
(c) Progress notes shall include chronological documentation of treatment that is directly related to the patient's treatment plan, and documentation of the patient's response to treatment.
DHS 75.24(16)(d)
(d) The person making the entry shall sign and date the note, and if a designee, shall indicate who provided the service.
DHS 75.24(17)(b)
(b) A service shall have written policies and procedures regarding group counseling that include, at minimum, the following:
DHS 75.24(17)(b)3.
3. Consideration of needs related to special populations or considerations for co-mingled groups.
DHS 75.24(17)(c)
(c) Each group therapy contact shall be documented as a progress note in each patient's case record.
DHS 75.24(18)(a)(a) When requested by a patient's affected family member or significant other, the service shall offer or refer for supportive services, such as counseling, support groups, or education.
DHS 75.24(18)(b)
(b) A service shall involve a patient's family members and significant others in assessment, treatment planning, transfers of care, safety planning, and discharge whenever feasible.
DHS 75.24(18)(c)
(c) A service shall have written policies and procedures to address confidentiality, conflicts of interest, and ethics related to family services.
DHS 75.24(19)(a)(a) All medical services provided under this chapter shall be provided by appropriately credentialed staff operating within their scope of practice,
DHS 75.24(19)(b)
(b) Prescribers providing substance use treatment services or supervision of substance use treatment services shall be knowledgeable in addiction treatment.
DHS 75.24(19)(c)
(c) For medical needs of a patient that exceed the scope of the service under this chapter, the service shall coordinate with appropriate medical providers.
DHS 75.24(19)(d)
(d) A service may offer medication management for treatment of substance use disorders or mental health disorders. A service shall have written policies and procedures for medication management services, including:
DHS 75.24(19)(d)2.
2. Prescriber checks and use of the Wisconsin Prescription Drug Monitoring Program database.
DHS 75.24(19)(d)3.
3. Procedures for obtaining and updating patient consents for medications received.
DHS 75.24(19)(d)4.
4. Procedures for reporting and reviewing medication errors via facility incident reports or other documentation.
DHS 75.24(19)(e)
(e) When a patient's treatment includes medication management, it shall be documented as a goal in the patient's treatment plan. The treatment plan shall be signed by the prescriber.
DHS 75.24(19)(f)
(f) If a patient is prescribed medication as part of the treatment plan, the service shall obtain a separate consent that indicates that the prescriber has explained to the patient, or the patient's legal representative, if applicable, the nature, risks and benefits of the medication and that the patient, or legal representative, understands the explanation and consents to the use of the medication.
DHS 75.24(19)(g)
(g) A service shall maintain medication records that allow for ongoing monitoring of any medication prescribed or administered by the service, and documentation of any adverse drug reactions or medication errors. Medication orders shall specify the name of the medication, dose, route of administration, frequency of administration, name of the prescriber who prescribed the medication, prescriber signature, and staff administering the medication, if applicable.
DHS 75.24(19)(h)
(h) A service that receives, stores, or dispenses medications shall have written policies and procedures regarding storage, dispensing, and disposal of medications, including:
DHS 75.24(19)(h)1.
1. Patient name, medication name, amount of medication, dosage, date of receipt, and date of dispensing or disposal.
DHS 75.24(19)(i)
(i) A non-residential service that receives, stores, or dispenses medications shall comply with
21 CFR 1301.72. The medication storage area shall be clean, and shall be separated by a wall from any restroom, cleaning products, or any food-preparation or storage area.
DHS 75.24(20)(a)(a) A service shall have written policies and procedures for drug testing, breath analysis, and toxicology services. Patients of a service shall be informed of these policies and procedures upon admission.
DHS 75.24(20)(b)
(b) A service may utilize drug testing information in conjunction with patient self-report, behavioral observations, collateral information, and clinical assessment to make determinations regarding patient care.
DHS 75.24(20)(c)
(c) A service shall have a method for obtaining confirmation of drug testing results.
DHS 75.24(20)(d)
(d) A service shall inform patients of the costs for drug testing services.
DHS 75.24(20)(e)
(e) A service shall obtain informed consent before releasing patient drug testing results. The service is responsible for ensuring that the patient understands possible consequences of disclosure of drug testing information.
DHS 75.24(21)
(21)
Transfer. If the service transfers a patient to another provider or if a change is made in the patient's level of care, the transfer or change in the level of care shall be documented in the patient's case record. A transfer summary shall be entered into the patient's case record, including the following:
DHS 75.24(21)(b)
(b) A completed copy of the standardized placement criteria and level of care recommended.
DHS 75.24(21)(c)
(c) Documentation of communication and follow-up that ensures continuity of care from one provider or level of care to another.
